Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]INTERMEDIATE SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
62
PharmaCompass offers a list of Afamelanotide API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Afamelanotide manufacturer or Afamelanotide supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Afamelanotide manufacturer or Afamelanotide supplier.
A Afamelanotide manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Afamelanotide, including repackagers and relabelers. The FDA regulates Afamelanotide manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Afamelanotide API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Afamelanotide manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.
A Afamelanotide supplier is an individual or a company that provides Afamelanotide active pharmaceutical ingredient (API) or Afamelanotide finished formulations upon request. The Afamelanotide suppliers may include Afamelanotide API manufacturers, exporters, distributors and traders.
click here to find a list of Afamelanotide suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.
A Afamelanotide DMF (Drug Master File) is a document detailing the whole manufacturing process of Afamelanotide active pharmaceutical ingredient (API) in detail. Different forms of Afamelanotide DMFs exist exist since differing nations have different regulations, such as Afamelanotide USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Afamelanotide DMF submitted to regulatory agencies in the US is known as a USDMF. Afamelanotide USDMF includes data on Afamelanotide's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Afamelanotide USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Afamelanotide suppliers with USDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Afamelanotide as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Afamelanotide API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Afamelanotide as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Afamelanotide and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Afamelanotide NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Afamelanotide suppliers with NDC on PharmaCompass.
Afamelanotide Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Afamelanotide GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Afamelanotide GMP manufacturer or Afamelanotide GMP API supplier for your needs.
A Afamelanotide CoA (Certificate of Analysis) is a formal document that attests to Afamelanotide's compliance with Afamelanotide specifications and serves as a tool for batch-level quality control.
Afamelanotide CoA mostly includes findings from lab analyses of a specific batch. For each Afamelanotide CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Afamelanotide may be tested according to a variety of international standards, such as European Pharmacopoeia (Afamelanotide EP), Afamelanotide JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Afamelanotide USP).
